Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 43.49 USD -0.14% Market Closed
Market Cap: 2B USD

Omnicell Inc
Depreciation & Amortization

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Omnicell Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Omnicell Inc
NASDAQ:OMCL
Depreciation & Amortization
$73.7m
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
12%
Veeva Systems Inc
NYSE:VEEV
Depreciation & Amortization
$39.6m
CAGR 3-Years
12%
CAGR 5-Years
3%
CAGR 10-Years
21%
Inspire Medical Systems Inc
NYSE:INSP
Depreciation & Amortization
$12.6m
CAGR 3-Years
97%
CAGR 5-Years
76%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Depreciation & Amortization
$10.7m
CAGR 3-Years
29%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Certara Inc
NASDAQ:CERT
Depreciation & Amortization
$68m
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Depreciation & Amortization
$186.6m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Omnicell Inc
Glance View

Omnicell Inc. stands at the intersection of healthcare and technology, sculpting the landscape of medication management systems with its innovative spirit. Founded in 1992, Omnicell has evolved from a small enterprise into a leading provider of automated solutions for medication and supply dispensing, inventory management, and analytics. The company’s core offering, its automated dispensing systems, reshapes how hospitals, pharmacies, and healthcare providers manage medications. By utilizing cutting-edge technology, Omnicell improves efficiency, reduces medication errors, and cuts down on healthcare costs. These systems are embedded in the workflow of healthcare facilities, ensuring that medication management becomes seamless, thus elevating patient safety and clinical outcomes. Revenue streams flow robustly from both product sales and associated services. Omnicell garners income by selling its advanced hardware systems, which include everything from pharmacy carousels to medication robotic systems, and supplements these sales with software solutions that offer predictive analytics and inventory optimization. Beyond the initial sale, a significant part of their business model includes recurring revenue through service contracts, software updates, and customer support. This dual approach not only ensures a steady cash flow but also strengthens customer relationships by consistently providing value over time. As the healthcare industry increasingly leans on technology for streamlined operations and cost management, Omnicell’s strategic positioning allows it to capitalize on the demand for sophisticated medication management solutions.

OMCL Intrinsic Value
40.1 USD
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Omnicell Inc's Depreciation & Amortization?
Depreciation & Amortization
73.7m USD

Based on the financial report for Sep 30, 2025, Omnicell Inc's Depreciation & Amortization amounts to 73.7m USD.

What is Omnicell Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
12%

Over the last year, the Depreciation & Amortization growth was -17%. The average annual Depreciation & Amortization growth rates for Omnicell Inc have been -5% over the past three years , 5% over the past five years , and 12% over the past ten years .

Back to Top